Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Ibandronic Acid Sandoz, ibandronic acid, Date of authorisation: 26/07/2011, Revision: 10, Status: Lapsed

Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Cinacalcet Viatris (previously Cinacalcet Mylan), cinacalcet, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Rapilysin, reteplase, Date of authorisation: 29/08/1996, Revision: 28, Status: Withdrawn

Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 15, Status: Authorised